Karen Lynn Chandler Johnson, MD, MPH WORK - Office of ...

CURRICULUM VITAE
NAME: Karen Lynn Chandler Johnson, M.D., M.P.H.
1
Date of Preparation: 2-24-2012
WORK: University of Tennessee, Health Science Center Preventive Medicine East Clinic
Department of Preventive Medicine 756 Ridgelake Blvd, suite 206
66 N. Pauline, Suite 633 Memphis, TN 38120
Memphis, TN 38163 Phone: (901) 767-4200
Phone: (901) 448-5900 Fax: (901) 767-3605
Fax: (901) 448-7041
E-mail: KJohnson@uthsc.edu
BIRTHPLACE: Memphis, Tennessee
MARITAL STATUS: Married
CURRENT POSITION:
EDUCATION:
Professor, University of Tennessee, Health Science Center, Joint appointment in the
Departments of Preventive Medicine and Medicine, 2004 - Present.
Interim Chair, University of Tennessee, Health Science Center, Department of Preventive
Medicine, 2010 - Present.
High School:
Memphis Preparatory School, Memphis, TN, attended September, 1970 - May, 1974, graduated
May, 1974.
Undergraduate:
B.S. in Biology, Lambuth College, Jackson, TN, attended September, 1974 - May, 1978,
graduated May, 1978.
Undergraduate Honors:
Magna cum laude
Gamma Beta Phi National Honor Society
Who's Who in American Colleges
Medical School and Graduate School:
M.D., University of Tennessee, Memphis, attended September, 1981 - June, 1985, graduated
June, 1985.
M.P.H. in Health Policy and Management, Johns Hopkins University, School of Hygiene and
Public Health, Baltimore, MD, attended July, 1988 - June, 1989, graduated June, 1989.

Residency/Fellowship:
Internal Medicine Resident, University of Tennessee, Memphis, July, 1985 - June, 1988.
Clinical Preventive Medicine Resident, Johns Hopkins University, Baltimore, MD, July, 1988 -
June, 1990.
Clinical Medicine Fellow, Department of Medicine, Johns Hopkins University, Baltimore, MD,
July, 1988 - June, 1990.
BOARD CERTIFICATION:
Board certified, American Board of Internal Medicine, 1988.
Board certified, American Board of Preventive Medicine, 1991.
MEDICAL LICENSURE:
Tennessee #MD017684, 1985 - present.
Maryland, 1988 - 1990.
SOCIETY MEMBERSHIPS:
Society for General Internal Medicine, 1989 - present.
American Public Health Association, 1989 - present.
American College of Physicians, 1990 - present.
American College of Preventive Medicine, 1992 - present.
American Heart Association, 1992 - present.
Society for Research on Nicotine and Tobacco, 1998 – present.
UNIVERSITY APPOINTMENTS:
Instructor, University of Tennessee, Health Science Center, College of Medicine, Department of
Preventive Medicine and Department of Medicine, July, 1990 - June, 1992.
Assistant Professor, University of Tennessee, Health Science Center, College of Medicine,
Department of Preventive Medicine and Department of Medicine, July, 1992 - 1998.
Appointed to the Graduate Faculty Category 1, University of Tennessee, Memphis, College of
Graduate Health Sciences, October, 1992.
Associate Professor, University of Tennessee, Health Science Center, College of Medicine,
Department of Preventive Medicine and Department of Medicine, July, 1998 - 2004.
Professor, University of Tennessee, Health Science Center, College of Medicine, Department of
Preventive Medicine and Department of Medicine, July, 2004-present.
2

Vice Chairman, University of Tennessee, Health Science Center, College of Medicine,
Department of Preventive Medicine and Department of Medicine, January 2000 - 2010.
Interim Chairman, University of Tennessee, Health Science Center, College of Medicine,
Department of Preventive Medicine and Department of Medicine, May 2010 - present.
HOSPITAL APPOINTMENTS:
University of Tennessee Bowld Hospital, Active Staff, 1990 - 2004.
Regional Medical Center at Memphis, Active Staff, 1990 - 2005.
Baptist Memorial Hospital, Courtesy Staff, 1990 - present.
Methodist Hospital, Courtesy Staff, 2000 - present.
OTHER HEALTH RELATED POSITIONS:
Medical Director, Clinical Trials Unit, Department of Preventive Medicine, University of
Tennessee, Memphis, 1995 - present.
Medical consultant (voluntary), Samaritan Counseling Center of the Mid-South, 1991 - 2003.
Accreditation Council for Graduate Medical Education, Residency Review Committee for
Preventive Medicine, Resident Member, 1989 - 1991.
Internist, Johns Hopkins Health Plan, January - December, 1989.
OTHER PRIVATE SECTOR POSITIONS:
Laboratory Technician, Coca Cola Company USA, Atlanta, GA, October, 1979 - 1981.
Research Laboratory Technologist, St. Jude Children's Research Hospital, Memphis TN,
September, 1978 - 1979.
INVITED PRESENTATIONS
An Update from the Women’s Health Initiative. Invited speaker for Michigan State Ob/Gyn statewide
residency program. Ann Arbor, Michigan. 2006.
The Side Effects of Hormone Replacement Therapy. Invited speaker for Bionova. New York, NY
2006.
The Women’s Health Initiative – Cancer Findings from the Hormone Trial. Invited speaker for the
Mid-South Cancer Symposium. Memphis, TN 2005.
Hormone Replacement Therapy in Postmenopausal Women – an Update. Invited speaker for
the National American Geriatrics Society Meeting, Orlando, FLA, 2005.
The Women’s Health Initiative Hormone Trials. Invited speaker for American College of
Physicians, Tennessee Chapter. Nashville, TN, 2004.
3

The Principal Results of the Women’s Health Initiative Estrogen plus Progestin Clinical Trial.
Invited speaker for Tennessee State University. Nashville, TN, 2004.
An Update from the Women’s Health Initiative Estrogen plus Progestin Clinical Trial. Invited
speaker for the Cardiovascular Institute sponsored by National Heart Lung and Blood Institute,
NIH at The 31st Annual Institute and Conference of the National Black Nurses Association, New
Orleans, LA, 2003.
Women’s Health and Changing Evidence: an Update from the Women’s Health Initiative. Invited
speaker at the 20th Annual Research Meeting for the Academy of Health, Nashville, TN, 2003
The Principal Results of the Women's Health Initiative Estrogen plus Progestin Clinical Trial.
Invited speaker, Grand Rounds, Evansville, IN, 2003.
The Principal Results of the Women's Health Initiative Estrogen plus Progestin Clinical Trial.
Invited speaker, Grand Rounds, Baton Rouge, LA, 2002.
Hormone Replacement and Cardiovascular Disease. Invited speaker at the 4th International
Symposium on Women’s Health and Menopause: New Strategies - Improved Quality of Life.
Washington, D.C., 2001
Adverse Event Collection Lecture. Look Ahead Training. Wake Forest, NC. May 2001.
Exercise and Cardiovascular Disease Lecture. Look Ahead Training. Wake Forest, NC. May
2001.
Two Ancillary Studies in the CHARM Participants. Major presenter at the site visit for the
General Clinical Research Center (GCRC) for consideration of funding by the NIH. University of
Tennessee, Memphis, 1997.
Ancillary Studies in the CHARM Participants. Major presenter at the site visit for the General
Clinical Research Center (GCRC) for consideration of funding by the NIH. University of
Tennessee, Memphis, 1996.
The Cardiovascular Effects of Norplant. Invited speaker at the Conference on Long Acting
Contraceptives. National Institutes of Health, National Institute of Child Health and Human
Development. Bethesda, MD. August, 1995.
INVITED PRESENTATIONS (Local)
Hormone Replacement Therapy and the Women’s Health Initiative. Presentation to the Rotary
Club. November, 2004.
Hormone Replacement Therapy and Cardiovascular Disease Lecture. National Heart Lung and
Blood Institute Conference, Memphis, TN, September 2000.
Smoking Cessation and Relation to Health. Presentation to the physicians at the Millington Naval
Hospital, Memphis, TN, 1997.
The TONE Study. Presentation at St Francis Hospital, 1997.
The Women's Health Initiative Experience. Presentation to gynecologists at Baptist East
Hospital, 1996.
4

Smoking Cessation and Disease Prevention. Presentation at Smoking Cessation Classes for the
Cardiac Wellness Center, Baptist Health Systems. Memphis, TN, 1994, 1995.
Smoking Cessation Classes for the employees at Smith and Nephew Richards Company.
Memphis, TN, 1993,1994.
Contraception in the 1990's. Presentation to the Methodist Hospital Internal Medicine Residents,
Memphis, TN, 1994.
Smoking Cessation Activities for the Workplace. Presentation as part of the "Heart at Work
Program" sponsored by the American Heart Association. Memphis, TN, 1994.
PRESENTATIONS AT THE UNIVERSITY OF TENNESSEE, MEMPHIS
Access to Over-the-counter NRT by Minors. Pediatric Roundtable, University of Tennessee,
2004
An Update from the Women Health Initiative Estrogen plus Progestin Clinical Trial. Obstetrics
and Gynecology Ground Rounds, University of Tennessee, 2003.
An Update from the Women Health Initiative Estrogen plus Progestin Clinical Trial. Medicine
Ground Rounds, University of Tennessee, 2003.
The Principal Results of the Women Health Initiative Estrogen plus Progestin Clinical Trial.
Preventive Medicine Research Meeting, University of Tennessee, 2002.
The Principal Results of the Women Health Initiative Estrogen plus Progestin Clinical Trial.
Medicine Ground Rounds, University of Tennessee, 2002.
Results of the TONE Study. Presentation at the Preventive Medicine Research Meeting, 1997.
The Women's Health Initiative. Presentation at The University Relations Forum (TURF), 1997.
Contraception in the 1990's. Presentation at the Universities Prevention Center Scientific
Luncheon, 1994.
Contraception. Presentation at the Memphis Preventive Medicine and Hypertension Coalition,
1994.
TEACHING EXPERIENCE:
University of Tennessee, Health Science Center
Course Director for the Clinical Trials Course for the Masters of Science in Epidemiology
students, 1999, 2000, 2001, 2002, 2003, 2004, 2005.
Preceptor for the PCC course for medical students. 2005, 2008, 2009, 2010.
TARGIT study. Preventive Medicine Third Thursday Conference. 2009.
Faculty Advisor for the Thesis Committee for Katie Suda, M.D. for the Master of Science Degree
in Epidemiology, 2008 - 2010.
5

Faculty Advisor for the Thesis Committee for Jane Hankins, M.D. for the Master of Science
Degree in Epidemiology, 2001 - 2004.
Faculty Advisor for the Thesis Committee for Laura Henderson, M.D. for the Master of Science
Degree in Epidemiology, 2003 - 2004.
Faculty Advisor for the Thesis Committee for Atosa Nikan, M.D. for the Master of Science Degree
in Epidemiology, 2000 - 2004.
Faculty Advisor for the Thesis Committee for Aditya Gaur, M.D. for the Master of Science Degree
in Epidemiology, 2001 - 2002.
Preceptor / Faculty Mentor for a premed student, Hayden Smith, in the NIH Medical Student
Summer Research Program. Summer 2001.
Clinical Trial Lecture to UT Otolaryngology Residents and Fellows. February, 2001.
Preceptor for an Independent Study Credit for a Masters of Epidemiology Student. Fall 2000.
Preceptor for Small Group Sessions for Preventive Medicine as part of the Longitudinal Program
for the 1st and 2nd year medical students at UT. Fall 2000.
Introduction to Clinical Skills Course. Preceptor for the second year medical students for sixteen
weekly sessions learning clinical skills at the bedside, 1994, 1998.
Epidemiology of Estrogen Use. Lecture given in the Interhospital Endocrine Rounds, 1999.
Estrogen Replacement Therapy. Lecture given to the Masters of Epidemiology students in the
Pharmacoepidemiology Course, 1999.
How to Help Your Patients Stop Smoking - Use of Nicotine Replacement Therapy. Lecture given
to the first year medical students in the Preventive Medicine Course, 1998.
Biostatistics for the Physician. Lecture to the first year medical students in the Preventive
Medicine Course, 1997.
How to Read the Medical Literature. Preceptor for a group of 8 - 10 first year medical students in
the Preventive Medicine Course, 1997.
Internal Medicine Journal Club. Preceptor for a group of 6 - 8 Internal Medicine Residents, 1997
- 1999.
How to Read the Medical Literature. Preceptor for a group of 8 - 10 first year medical students in
the Preventive Medicine Course, 1996.
Epidemiology: Comparison of Case Control and Cohort Studies. Lecture to the first year medical
students in the Preventive Medicine Course, 1995.
Estrogen and Progestin Use for the Clinician. Lecture to the fourth year medical students,1995.
How to Help Your Patients Stop Smoking - Use of Nicotine Replacement Therapy. Lecture given
to the Internal Medicine residents, 1995.
How to Read the Medical Literature. Preceptor for a group of 8 - 12 first year medical students in
the Preventive Medicine Course, 1995 - 1998.
6

Major Causes of Mortality in the U.S. and Preventable Risk Factors. Lecture to the first year
medical students in the Preventive Medicine Course, 1994.
The Health Consequences of Smoking. Lecture in the Preventive Medicine Course to the first
year medical students, 1994.
Contraceptive and Postmenopausal Hormonal Use in Women. Lecture to the fourth year medical
students, 1994.
Smoking and its Consequences. Lecture to Doctor of Pharmacy students, 1994.
The Process of Clinical Thinking. Lecture in the Introduction to Clinical Skills Course to the
second year medical students, 1994.
How to Read the Medical Literature. Preceptor for a group of 8 - 10 first year medical students in
the Preventive Medicine Course, 1994.
Clinical Thinking. Lecture in the Introduction to Clinical Skills Course to the second year medical
students, 1993.
Clinical Preventive Medicine. Lecture to the Internal Medicine Residents, 1993.
Women's' Health and Clinical Preventive Medicine. Lecture in the Preventive Medicine Course to
the first year medical students, 1993.
Estrogen and Progestin Use. Lecture to the fourth year medical students,1993.
How to Read the Medical Literature. Preceptor for a group of 8 - 10 first year medical students in
the Preventive Medicine Course, 1993.
How to Help Your Patients Stop Smoking. Lecture given to the Internal Medicine residents,
University of Tennessee, 1993.
How to Help Your Patients Stop Smoking. Lecture given to the Internal Medicine residents,
University of Tennessee, 1992.
Smoking and its Health Consequences. Lecture in the Preventive Medicine Course to the first
year medical students, 1992.
Clinical Thinking for the Physician. Lecture in the Introduction to Clinical Skills Course to the
second year medical students, 1992.
Epidemiologic Research for Internal Medicine Faculty. Developed a research seminar for the
general internal medicine faculty, 1992.
Smoking and Health Consequences. Lecture in the Preventive Medicine Course to the first year
medical students, 1991.
Smoking Related Illness. Lecture to the third year medical students in the Internal Medicine
Rotation, 1991.
Epidemiology for the Physician. Series of lectures given to the second year medical students,
1990.
7

Attending Physician at the University of Tennessee, Health Science Center
Medicine attending for Internal Medicine Residents and third and fourth year medical students on
an inpatient Internal Medicine Service at the Regional Medical Center, Memphis, TN, 1991, 1992,
1993, 1994, 1995.
Medicine attending for Internal Medicine Residents and third and fourth year medical students on
an inpatient Internal Medicine Service at the UT Bowld Hospital, Memphis, TN, 1996,1997, 1998.
Medicine attending for Internal Medicine Residents and fourth year medical students in the
outpatient Internal Medicine Clinic at the Gailor Clinic, Memphis, TN, 1990, 1991, 1992, 1993,
1994.
Preventive Medicine attending for Internal Medicine Residents during a Preventive Medicine
elective, Memphis, TN, 1997.
RESEARCH AND OTHER EXTRAMURAL SUPPORT:
NIH Funded Research Projects
Role on Project: Principal Investigator
Targeted Approaches to Weight Control for Young Adults (TARGIT). Principal Investigator:
Karen C. Johnson, MD, MPH. Experience gained in this multicenter clinical trial of intentional
weight gain prevention in young adults smokers who quit smoking. Funded by the National
Heart, Lung, and Blood Institute, NIH (UO1HL096628). $4,427,252. 2009 – 2014.
Look AHEAD (AKA Study of the Health Effects of Weight Loss previously SHOW). Principal
Investigator: Karen C. Johnson, MD, MPH. Experience gained in this multicenter trial of
intentional weight loss in obese type II diabetics. Funded by the National Institute of Diabetes,
Digestive Disorders, and Kidney Disease, NIH (UO1-DK57078) $13,904,930. 1999 – 2014.
Intentional weight reduction and physical and cognitive function (Look AHEAD Ancillary Study).
Principal Investigator: Karen C. Johnson, MD, MPH. Experienced gained in accessing physical
and cognitive function in diabetic participants in Look AHEAD. Funded by the National Institute on
Aging, NIH. $547,704. 2009-2014.
Women's Health Initiative (WHI). Principal Investigator: Karen C. Johnson, MD, MPH.
Experienced gained in a multi-center randomized clinical trial and observational study of
postmenopausal women's health in relation to hormone replacement, low fat diet, or
calcium/vitamin D supplementation. Funded by the National Heart, Lung, and Blood Institute,
NIH. (NO1-WH-2118). $15,305,404. 1993 – 2010.
Women's Health Initiative (WHI) Extension Study 2010-2015. Principal Investigator: Karen C.
Johnson, MD, MPH. Experienced gained in observational study of postmenopausal women's
health. Funded by the National Heart, Lung, and Blood Institute, NIH with a subcontract to Wake
Forest. 2010 - 2015.
Recovery act administrative supplement to the Look AHEAD study. Principal Investigator: Karen
C. Johnson, MD, MPH. Funded by National Institute of Diabetes, Digestive Disorders, and Kidney
Disease, NIH. $137,197. 2009-2012.
8

Systolic Blood Pressure Intervention Trial (SPRINT). Co-Chair of the National Steering
Committee and Principal Investigator. Karen C. Johnson, MD, MPH. Funded by the National
Heart Lung and Blood Institute, NIH. UT has subcontract with Wake Forest and UAB for the
SPRINT study. 2010 – 2015.
A Clinical Trial of Two Medications on Smoking Cessation (STAR). Principal Investigator: Karen
C. Johnson, MD, MPH. Experienced gained in a randomized clinical trial to assess whether a
combination of the nicotine patch and sustained-release bupropion as compared to the nicotine
patch or sustained-released bupropion alone will result in increased initial and longterm smoking
cessation in younger low income and minority persons who smoke. Funded by the National
Heart Lung and Blood Institute, NIH (RO1 HL66025-01A1). $2,721,618. 2002 - 2008.
The Use of Sibutramine in Smoking Cessation (SUCCESS). Principal Investigator: Karen C.
Johnson, MD, MPH. Experienced gained in a randomized clinical trial to assess whether
sibutramine compared to a placebo can prevent postcessation weight gain and help smokers
stop smoking. Funded by the National Heart Lung and Blood Institute, NIH (RO1HL68049-01).
$2,463,873. 2001 - 2007.
Treating Nicotine Addiction in Pregnancy (RENEW). Principal Investigator: Karen C. Johnson,
MD, MPH. Experienced gained in a clinical trial looking at the efficacy of the Nicotine patch in
pregnant women smokers. RO1 Grant funded by the National Institute of Drug Abuse, NIH.
$349,896. 1997 - 2001.
Bone Mineral Density in CHARM Participants. Principal Investigator: Karen C. Johnson, MD,
MPH. Experience gained in assessing the effects of hormonal contraceptives on bone mineral
density by DEXA scan in premenopausal women. Grant funded by the Office of Research on
Women's Health, NIH. $99,980. 1995 - 1999.
Effect of Norplant on Cardiovascular Risk in Young Women (CHARM). Principal Investigator:
Karen C. Johnson, MD, MPH. Experienced gained in a clinical trial looking at hormonal
contraceptives and cardiovascular risk in premenopausal women. RO1 Grant funded by the
National Institute of Child Health and Human Development, NIH. $1,151,759. 1994 - 1999.
Women's Health Initiative Memory Study (WHIMS). Principal Investigator: Karen C. Johnson,
MD, MPH. Experienced gained in a multi-center randomized clinical trial examining the effect of
postmenopausal hormone replacement therapy on the development of dementia in women age
65 years and older in the Women's Health Initiative study. Ancillary to an NIH funded grant.
$247,477. 1996 - 2007.
Women’s Health Initiative Sight Exam Study (WHISE). Principal Investigator: Karen C. Johnson,
MD, MPH. Experienced gained in a multi-center randomized clinical trial examining the effect of
postmenopausal hormone replacement therapy on the development acute macular degeneration.
Ancillary to an NIH funded grant. $340,000. 2000 - 2005.
Benign Breast Disease in the Women’s Health Initiative. Principal Investigator: Karen C.
Johnson, MD, MPH. Experienced gained in a multi-center randomized clinical trial examining the
effect of postmenopausal hormone replacement therapy on the development of benign breast
disease. Ancillary to an NIH funded grant. $46,384. 2002 – 2005.
Women’s Health Initiative Nutritional Biomarkers Study (NBS). Principal Investigator: Karen C.
Johnson, MD, MPH. Experience gained in a multi-center study examining objective (i.e., blood
and urine) measures of dietary intake to use in regression calibration models of dietary intake in
the Women’s Health Initiative. Ancillary to an NIH funded grant. 2006 – 2008.
9

Women’s Health Initiative Nutrition and Physical Activity Assessment Study (NPAAS). Principal
Investigator: Karen C. Johnson, MD, MPH. Experience gained in a multi-center study examining
objective (i.e., blood and urine) measures of dietary intake and physical activity to use in
regression calibration models of dietary intake in the Women’s Health Initiative. Ancillary to an
NIH funded grant. 2007 – 2009.
NIH Funded Research Projects
Role on Project: Co-Investigator
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL. Principal
Investigator: Keri Ness, PhD, Co-Investigator: Karen C. Johnson, MD, MPH. Experience gained
in assessing physical Function in ALL survivors. Funded by National Cancer Institute, NIH. (R01
CA132901). Subcontract with St Jude. $62,395. 2009 – 2013.
Airforce III Smoking Cessation Study. Principal Investigator: Robert C. Klesges, PhD, Co-
Investigator: Karen C. Johnson, MD, MPH. Experienced gained with a smoking cessation quitline
in the military. Funded by the National Heart Lung and Blood Institute, NIH. $3,672,552. 2008 –
2013.
Step Smoking Cessation Study (STEP). Principal Investigator: Robert C. Klesges, PhD. Co-
Investigator: Karen C. Johnson, MD, MPH. Experienced gained with a smoking cessation and
step care therapy. Funded by the National Heart Lung and Blood Institute, NIH. $2,036,957. 2007
– 2012.
Change Smoking Cessation Study (CHANGE). Principal Investigator: Robert C. Klesges, PhD.
Co-Investigator: Karen C. Johnson, MD, MPH. Experienced gained with a smoking cessation.
Funded by the National Heart Lung and Blood Institute, NIH. $2,340,070. 2008 – 2013.
Treating Childhood Obesity with Family Lifestyle Change (TEAM Play). Principal Investigator:
Grant Somes, PhD followed by Marion Hare, MD. Co-Investigator: Karen C. Johnson, MD, MPH.
Randomized clinical trial to prevent obesity in children using a family lifestyle intervention based
in primary care practices. Funded by the National Institute of Child Health and Human
Development, NIH (RO1-HD050895). $2,166,760. 2005-2010
Increasing Physical Activity to Aid Smoking Cessation (LEAP). Principal Investigator: Kenneth
Ward, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Randomized trial to determine if
physical activity can assist with smoking cessation. Funded by the National Heart Lung and
Blood Institute, NIH. (RO1 - HL68569). $2,550,440. 2003 – 2008.
A Randomized Trial to Reduce Sedentary Behavior in the Working Poor (HOPE). Principal
Investigator: Robert Garrison, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Experience
gained in testing the efficacy of different behavior change models on the adoption of exercise in
sedentary adults. Funded by the National Cancer Institute, NIH. $1,980,072. 1999 - 2003.
Nicotine Replacement and Oxidative Stress in Pregnancy. Principal Investigator: Lisa Klesges,
PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Experience gained in smoking cessation
and antioxidant status in pregnant smokers. Funded by the National Institute of Child Health and
Human Development, NIH. $99,000. 1998 - 2002.
Nicotine Replacement Therapy in the Elderly (SITE). Principal Investigator: Robert C. Klesges,
PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Experience gained in smoking cessation
techniques in the elderly. Funded by the National Cancer Institute, NIH. $1,928,871. 1998 -
2003.
10

Dynamics of Health, Aging, and Body Composition (Health ABC Study). Principal Investigator:
Suzanne Satterfield, MD, DrPH. Co-Investigator: Karen C. Johnson, MD, MPH. This study is
examining the effect of body composition on physical function in relation to morbidity and
mortality events in 3000 persons age 70 to 79. Funded by the National Institute on Aging, NIH.
(NO1 AG 6 2103). $9,400,409. 1996 - 2012.
Nicotine Replacement Therapy and Behavioral Therapy in Primary Care Settings (NRT).
Principal Investigator: Robert C. Klesges, PhD. Co-Investigator: Karen C. Johnson, MD, MPH.
Experience gained in smoking cessation techniques in primary care settings. Funded by the
National Cancer Institute, NIH. $1,928,871. 1996 - 2001.
Activity Counseling Trial (ACT). Principal Investigator: William B. Applegate, MD, MPH. Co-
Investigator: Karen C. Johnson, MD, MPH. This study is examining the effectiveness of a
primary care practice based exercise intervention to increase the physical fitness level of
sedentary adults. Funded by the National Heart, Lung, and Blood Institute, NIH. $2,067,947.
1994 - 1999.
Mechanisms Underlying Abnormal Ambulatory BP Patterns. Principal Investigator: Gregory A.
Harshfield, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Experienced gained on the
mechanisms of hypertension. Funded by the National Heart, Lung, and Blood Institute, NIH.
$254,600. 1993 - 1996.
Trial of Nonpharmacologic Therapy for Hypertension in the Elderly (TONE). Principal
Investigator: William B. Applegate, MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH.
Experienced gained in a multi-center randomized clinical trial about nonpharmacologic therapy
for the treatment of hypertension. Funded by the National Institute on Aging and National Heart,
Lung, and Blood Institute, NIH $1,401,191. 1992 - 1996.
Pharmacologic Intervention for Post-cessation Weight Gain: Principle Investigator: Robert C.
Klesges, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Experience gained in smoking
cessation and post-cessation weight gain. Funded by the National Heart, Lung, and Blood
Institute, NIH. $2,523,223. 1991 - 1996.
AERDS II Clinical Center. Principal Investigator: Alessandro Iannaccone, MD, MS. Coinvestigator:
Karen C. Johnson, MD, MPH. Funded by National Eye Institute. 2006-2008.
General Clinical Research Center (GCRC) Funded Research Projects
Role on Project: Principal Investigator
The Use of Sibutramine in Smoking Cessation (SUCCESS). Principal Investigator: Karen C.
Johnson, MD, MPH. Support for the NIH funded study in the form of study medication provided
by the General Clinical Research Center (GCRC) at the University of Tennessee, Memphis.
Parent study funded by the National Heart Lung and Blood Institute, NIH (RO1HL68049-01).
2001 - 2007.
Bone Mineral Density in Firemen: Is Sweat Important? Principal Investigator: Karen C.
Johnson, MD, MPH. Experience gained in assessing bone mineral density in men and collecting
sweat in a field setting. Funded by the General Clinical Research Center (GCRC) at the
University of Tennessee, Memphis. 1996 - 1997.
The Effect of Low Dose Contraception on Plasma Renin Activity in CHARM Participants.
Principal Investigator: Karen C. Johnson, MD, MPH. Experience gained in the effect of hormonal
contraception on the renin angiotensin system. Funded by the General Clinical Research Center
(GCRC) at the University of Tennessee, Memphis. 1994 - 1998.
11

TONE Ancillary Insulin Study. Principal Investigator: Karen C. Johnson, MD, MPH.
Experienced gained in hypertension and the relationship of glucose tolerance and
hyperinsulinemia. Funded by the General Clinical Research Center (GCRC) at the University of
Tennessee, Memphis. 1993 - 1996.
A Randomized, Double blind, Placebo-controlled, Clinical Trial to Study the Effects of the 21 mg
Nicotine Patch as Compared to Placebo Patch on Blood Glucose and Insulin Levels in
Premenopausal Women Smokers. Principal Investigator: Karen C. Johnson, MD, MPH.
Experience gained in smoking cessation and body weight. Funded by the General Clinical
Research Center (GCRC) at the University of Tennessee, Memphis. 1992 - 1998.
General Clinical Research Center (GCRC) Funded Research Projects
Role on Project: Co-Investigator
A Clinical Trial of OTC Therapy for Vasomotor Symptoms-Pilot. Principal Investigator: Margret
DeBon, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. This study examined the effect of
the nicotine patch on vasomotor symptoms in postmenopausal women. Funded by the General
Clinical Research Center (GCRC) at the University of Tennessee, Memphis. 2004 – 2007.
Assessment of Androgenic Hormones in Patients with Coronary Heart Disease: Relationship to
Insulin Resistance, Truncal Obesity, and Hyperlipidemia. Principal Investigator: Marshall B.
Elam, MD, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. This study examined the
association of lower DHEA levels, insulin resistance, and truncal obesity in persons with
cardiovascular disease compared to age matched controls. Funded by the General Clinical
Research Center (GCRC) at the University of Tennessee, Memphis. 1997 - 1999.
Bone Turnover Markers in CHARM Participants. Principal Investigator: Suzanne Satterfield, MD,
DrPH. Co-Principal Investigator: Karen C. Johnson, MD, MPH. Experience gained in assessing
the effects of hormonal contraceptives on bone turnover markers in premenopausal women.
Funded by the General Clinical Research Center (GCRC) at the University of Tennessee,
Memphis. 1994 - 1998.
Other Research Projects
Role on Project: Principal Investigator
BRIDGES Study. A multicenter clinical trial to evaluate a new measure for urinary incontinence.
Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Pfizer Inc. with a subcontract
with UCSF. $101,611. 2008 – 2010.
ExCel Study. An international multicenter clinical trial to determine if an aromatase inhibitor can
prevent breast cancer in postmenopausal women at high risk for breast cancer. Principal
Investigator: Karen C. Johnson, MD, MPH. Funded by National Cancer Institute of Canada.
$800,000. 2004 – 2011.
CHIMES. A multicenter clinical trial to investigate if a mixture of Chinese herbs can relieve
vasomotor symptoms in postmenopausal women. Principal Investigator: Karen C. Johnson, MD,
MPH. Funded by Bionova. $243,084. 2005-2007.
12

Medal. A Clinical trial to examine the effects of an investigational drug on osteoarthritis and
rheumatoid arthritis. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Novartis.
$20,184. 2003 - 2006.
Coral Study. Clinical trial to examine the effects of an investigational drug on osteopenia.
Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Pfizer Inc. $107,303. 2003 -
2005.
Pharmaceutical Study using an investigational drug for smoking cessation. Principal Investigator:
Karen C. Johnson, M.D., M.P.H. Funded by Sanofi Syntholabo. $250,000. 2002-2004.
Horizon Study. A Clinical trial to examine the effects of an investigational drug on osteoporosis.
Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Novartis. $143,588. 2002 -
2007.
Pearl Study. A Clinical trial to examine the effects of an investigational drug on osteoporosis.
Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Pfizer Inc. $739,516. 2001 -
2008.
Pharmaceutical Study on Bone Mineral Density and Contraception. . Principal Investigator:
Karen C. Johnson, MD, MPH. Funded by Pharmacia Upjohn. $117,500. 2001- 2004.
Angelique Study. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Berlex.
$38,288. 2001 - 2003.
Ultra Study. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Berlex. $150,000.
2000-2003.
Preference Study. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Merck & Co.,
Inc. $30,000. 2000-2001.
Soy Intervention Program (SIP). Principal Investigator: Karen C. Johnson, MD, MPH. Funded
by Protein Technologies. $180,000. 1999 - 2000.
Access of Over-the-Counter Nicotine Replacement Therapy Products by Minors. Principal
Investigator: Karen C. Johnson, MD, MPH. Experienced gained in access to nicotine
replacement products (patch and gum) by minors in the Memphis area. Grant funded by the
Partnership For Women's and Children's Health. $24,000. 1997 - 1998.
Exercise Counseling by Resident Physician Project. Principal Investigator at the University of
Tennessee, Memphis Site: Karen C. Johnson, MD, MPH. Coordinating Center Principal
Investigator: Laura Rogers, MD. Augusta GA. Experienced gained in a multi-center study
assessing exercise counseling given by resident physicians in their continuity care clinic. No
extramural funding. 1997.
Pharmaceutical Study on Prevention of Osteoporosis. Principal Investigator: Karen C. Johnson,
MD, MPH. Funded by SmithKline Beecham Pharmaceuticals. $431,400. 1997 - 1999.
Pharmaceutical Study on Vasomotor Symptoms. Principal Investigator: Karen C. Johnson, MD,
MPH. Funded by Advanced Care Products. $32,000. 1997 - 1998.
Pharmaceutical Study on Bone Mineral Density and Contraception. Principal Investigator: Karen
C. Johnson, MD, MPH. Funded by the UpJohn Company. $360,000. 1994 - 2002.
The Effect of a Physician Smoking Cessation Educational Program on Patient Smoking
Cessation Rates Measured by Salivary Cotinine Levels: A Randomized Clinical Trial. Principal
13

Investigator: Karen C. Johnson, MD, MPH. Experience gained in physician education and
smoking cessation interventions on patient behavior. Funded by the University of Tennessee
Medical Group (UTMG). $12,000. 1991 - 1994.
Injury Prevention: Are Smoke Detectors Important? Principal Investigator: Karen C. Johnson,
MD, MPH. Experience with design and implementation of an injury prevention randomized
clinical trial looking at smoke detector acquisition or maintenance by high risk adults in the
medical outpatient clinic at Johns Hopkins Hospital. No extramural funding. 1989 - 1991.
Other Research Projects
Role on Project: Co-Investigator
Treatment of Hot Flashes in Breast Cancer Survivors: A Pilot Study. Principal Investigator:
Margret DeBon, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Susan G.
Komen Foundation: $247,572, 2005- 2008.
Pharmaceutical Study on Prevention of Osteoporosis. Principal Investigator: Suzanne Satterfield,
MD, DrPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Wyeth- Ayerst. $122,050
2001 - 2004.
Heart and Estrogen/progestin Replacement Study II (HERS - II). Principal Investigator: Suzanne
Satterfield, MD, DrPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Wyeth-
Ayerst. $184,899. 1998 - 2001.
Heart and Estrogen/progestin Replacement Study (HERS). Principal Investigator: William B.
Applegate, MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Wyeth- Ayerst.
$1,716,221. 1992 - 1998.
Pharmaceutical Study on Prevention of Osteoporosis. Principal Investigator: William B.
Applegate, MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by the Eli Lilly
Co. $448,632. 1994 - 1998.
Nicotine Replacement Therapy Products: Prevalence of Use and Sources of Access in Minors.
Principal Investigator: Lisa Klesges, Ph.D., Co-Investigator: Karen C. Johnson, MD, MPH.
Experience gained in assessing the prevalence of use of Nicotine Replacement Therapy in the
community. Funded by the Partnership for Women's and Children's Health, $30,000. 1997 -
1998.
Pharmaceutical Study with Antihypertensive Agents. Principal Investigator: William B. Applegate,
MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Merck & Co., Inc.
$26,700. 1997 - 1998.
Pharmaceutical Study with Anticlaudication Agents. Principal Investigator: Marshall B. Elam,
MD, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Otsuka America
Pharmaceuticals, Inc. $38,440. 1997 - 1998.
Pharmaceutical Study with Antihypertensive Agents. Principal Investigator: William B.
Applegate, MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by SmithKline
Beecham. $62,370. 1997 - 1998.
Pharmaceutical Study with Antilipid Agents. Principal Investigator: Marshall B. Elam, MD, PhD.
Co-Investigator: Karen C. Johnson, MD, MPH. Project examined the effects of aggressive lipid
lowering on cardiovascular events. Funded by Parke Davis. $337,500. 1995 - 1998.
14

Pharmaceutical Study with Antihypertensive Agents. Principal Investigator: Gale Hamann,
PharmD. Co-Investigator: Karen C. Johnson, MD, MPH. Experience gained in a clinical
pharmacist's model of drug modification for the treatment of hypertension. Funded by Ciba
Geigy. $25,000. 1993 – 1994
Improving Resident Management of Hypercholesterolemic Patients: A Randomized Clinical Trial.
Principal Investigator: Laura Q. Rogers, MD. Co-Investigator: Karen C. Johnson, MD, MPH.
Experience gained in physician education and cholesterol management of high-risk patients.
Funded by the American Heart Association. $50,000. 1992 - 1995.
ORIGINAL RESEARCH PUBLICATIONS AND OTHER PUBLICATIONS
Publications (Journals)
Kroenke CH, Caan BJ, Stefanick ML, Anderson G, Brzyski R, Johnson KC, LeBlanc E, Lee C,
La Croix AZ, Park HL, Sims ST, Vitolins M, Wallace R. Effects of a dietary intervention and
weight change on vasomotor symptoms in the Women’s Health Initiative. In press in Menopause.
2012
Bertone-Johnson E, McTiernan A, Thomson C, Wactawski-Wende J, Aragaki A, Rohan T,
Vitolins M, Tamimi R, Johnson KC, Lane D, Rexrode K, Peck J, Chlebowski R, Sarto G, Manson
J. Vitamin D and calcium supplementation and one-year change in mammographic density in the
Women's Health Initiative Calcium and Vitamin D Trial. In press Cancer Epidemiology,
Biomarkers & Prevention. 2012
Neiberg RH, Wing R, Bray GA, Reboussin DM, Rickman AD, Johnson KC, Kitabchi AE,
Faulconbridge L, Kitzman D, Espeland MA, and the Look AHEAD Research Group. Patterns of
Weight Change Associated with Long-Term Weight Change and Cardiovascular Disease Risk
Factors in the Look AHEAD Study. In press in Obesity. 2012
Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, Rosendaal F,
Rosing J, Wasserthal-Smoller S, Martin LW, Manson JE, Lakshminarayan K, Merino JG, Lynch
J. Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due
to postmenopausal hormone therapy. Stroke. 2012; published online before print February 23
2012’doi:10.1161/STROKEAHA.111.643072.
Schwartz AV, Johnson KC, Kahn SE, Shepherd JA, Nevitt MC, Peters AL, Walkup MP, Hodges
A, Williams CC, Bray GA; Look AHEAD Research Group. Effect of one year of an intentional
weight loss intervention on bone mineral density in type 2 diabetes: Results from the look AHEAD
randomized trial. J Bone Miner Res. 2011 Dec 2. doi: 10.1002/jbmr.1483. [Epub ahead of print]
PubMed PMID: 22140018.
Mount DL, Davis C, Kennedy B, Ratz S. Dotson K, Gary TL, Thomas S, Johnson KC, Espeland
MA. Factors Influencing Enrollment of African Americans in the Look AHEAD Trial. Clinical
Trials. 2011 Nov 7. [Epub ahead of print]
Eaton CB, Young A, Allison MA, Robinson J, Martin LW, Kuller LH, Johnson KC, Curb JD, Van
Horn L, McTiernan A, Liu S, and Manson JE. Prospective association of vitamin D concentrations
with mortality in postmenopausal women: results from the Women's Health Initiative (WHI). Am J
Clin Nutr. 2011 Oct 26. [Epub ahead of print]
Neuhouser ML, Manson JE, Millen A, Pettinger M, Margolis K, Jacobs ET, Shikany JM, Vitolins
M, Adams-Campbell L, Liu S, LeBlanc E, Johnson KC, Wactawski-Wende J. The influence of
health and lifestyle characteristics on the relationship of serum 25(OH)D with risk of colorectal
and breast cancer in postmenopausal women. In press Am J Epidemiol 2011.
15

Prentice RL, Mossavar-Rahmani Y, Huang Y, Van Horn L, Beresford SA, Caan B, Tinker L,
Schoeller D, Bingham S, Eaton CB, Thomson C, Johnson KC, Ockene J, Sarto G, Heiss G and
Neuhouser ML. Evaluation and comparison of food records, recalls, and frequencies for energy
and protein assessment using recovery biomarkers. Am J Epidemiol. 2011 Jul 15. [Epub ahead
of print]
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT,Wactawski-Wende J,
McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ,
Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H for the NCIC CTG MAP.3 Study
Investigators. Exemestane for Breast-Cancer Prevention in Postmenopausal Women. N Engl J
Med 2011;364:2381-91.
LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL,
Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J; for the WHI
Investigators. Health outcomes after stopping conjugated equine estrogens among
postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA
2011;305(13):1305-1314.
Dumitrescu L, Carty CL, Taylor K, Schumacher FR, Hindorff LA, Ambite JL, Anderson G, Best
LG, Brown-Gentry K, Bůžková P, Carlson CS, Cochran B, Cole SA, Devereux RB, Duggan D,
Eaton CB, Fornage M, Franceschini N, Haessler J, Howard BV, Johnson KC, Laston S, Kolonel
LN, Lee ET, Maccluer JW, Manolio TA, Pendergrass SA, Quibrera M, Shohet RV, Wilkens LR,
Haiman CA, Le Marchand L, Buyske S, Kooperberg C, North KE, Crawford DC. Genetic
determinants of lipid traits in diverse populations from the Population Architecture using
Genomics and Epidemiology (PAGE) Study. PLoS Genet. 2011 Jun;7(6):e1002138. Epub 2011
Jun 30
Sims ST, Larson JC, LaMonte MJ, Michael YL, Martin LW, Johnson KC, Sarto GE, Stefanick
ML. Physical Activity and Body Mass: Changes in Younger vs Older Postmenopausal Women.
Med Sci Sports Exerc 2011 Jun 8. [Epub ahead of print]
Szmuilowicz ED, Manson JE, Rossouw JE, Howard BV, Margolis KL, Greep NC, Brzyski RG,
Stefanick ML, O'Sullivan MJ, Wu C, Allison M, Grobbee DE, Johnson KC, Ockene JK,
Rodriguez BL, Sarto GE, Vitolins MZ, Seely EW. Vasomotor symptoms and cardiovascular
events in postmenopausal women. Menopause. 2011 Feb 19. [Epub ahead of print]
Robinson JG, Manson JE, Larson J, Liu S, Song Y, Howard BV, Phillips L, Shikany JM, Allison
M, Curb JD, Johnson KC, Watts N. Lack of association between 25(OH)D levels and incident
type 2 diabetes in older women. Diabetes Care. 2011 Feb 2. [Epub ahead of print]
Casanova R, Espeland MA, Goveas JS, Davatzikos C, Gaussoin SA, Maldjian JA, Brunner RL,
Kuller LH, Johnson KC, Mysiw WJ, Wagner B, Resnick SM; for the Women's Health Initiative
Memory Study. Application of machine learning methods to describe the effects of conjugated
equine estrogens therapy on region-specific brain volumes. Magn Reson Imaging. 2011 Feb 1.
[Epub ahead of print]
Prentice RL, Huang Y, Kuller LH, Tinker LF, Van Horn L, Stefanick ML, Sarto G, Ockene J,
Johnson KC. Biomarker-Calibrated Energy and Protein Consumption and Cardiovascular
Disease Risk Among Postmenopausal Women. Epidemiology. 2011 Jan 4. [Epub ahead of print]
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick
ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix
SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL, For the WHI Investigators. Influence of
Estrogen Plus Progestin on Breast Cancer Incidence and Mortality in Postmenopausal Women.
JAMA 2010;304 (15): 1684-1692.
16

Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg CL, Wactawski-Wende J, Rohan
T, O’Sullivan MJ, Yasmeen S, Hiatt HA, Shikany JM,Vitolins M, Khandekar J, Hubbell FA.
Calcium plus Vitamin D Supplementation and 25-Hydroxyvitamin D Levels and Joint Symptoms
in Postmenopausal Women. Maturitas. 18 Nov 2010. [Epub ahead of print]
The Look AHEAD Research Group (author KC Johnson). Long-term Effects of a Lifestyle
Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes
Mellitus Four-Year Results of the Look AHEAD Trial. Arch Intern Med. 2010;170(17):1566-1575
Lipska KJ, Rekeneire ND, Van Ness PH. Johnson KC, Kanaya A, Koster A, Strotmeyer ES,
Goodpaster BH, Harris T, Gill TM, Inzucchi SE, for the Health ABC Study. Identifying
Dysglycemic States in Older Adults: Implications of the Emerging Use of Hemoglobin A1c. J Clin
Endocrinol Metab. 2010 Dec;95(12):5289-95. Epub 2010 Sep 22.
Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O’Sullivan MJ,
Wactawski-Wende J, Yasmeen S, Prentice R. Alcohol Consumption and Risk of Postmenopausal
Breast Cancer by Subtype: the Women’s Health Initiative Observational Study. J Natl Cancer Inst
2010 Sep 22;102(18):1422-31. [Epub 2010 Aug 23].
Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, Rodabough RJ,
Johnson KC, Wactawski-Wende J, Kotchen JM, Ockene JK, O’Sullivan MJ, Hubbell FA, Chien
JW, Chen C, Stefanick ML. Lung cancer among postmenopausal women treated with estrogen
alone in the Women’s Health Initiative Randomized Trial. J Natl Cancer I. 2010 Aug 13. [Epub
ahead of print]
Prentice RL, Paczesny SJ, Aragaki A, Amon LM, Chen L, Pitteri SJ, McIntosh M, Wang P, Busald
Buson T, Hsia J, Jackson RD, Rossouw JE, Manson JE, Johnson KC, Eaton C, Hanash SM.
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal
women identified by in-depth plasma proteome profiling. Genome Med. 2010 Jul 28;2(7):48.
[Epub ahead of print]
Carbone LD, Johnson KC, Robbins J, Larson JC, Curb JD, Watson K, Gass M, LaCroix AZ.
Anticonvulsant use, falls, fractures and BMD in postmenopausal women: Findings from the
Women’s Health Initiative. Journal of Bone and Mineral Research. 2010. 25(4):873-881.
Allison MA, Manson JE, Aragaki A, Langer RD, Rossouw J, Curb D, Martin LW, Phillips L,
Stefanick ML, Cochrane BB, Sarto G, Barnhart J, O'Sullivan MJ, Johnson KC, Gass M, Trevisan
M, Woods NF. Vasomotor symptoms and coronary artery calcium in postmenopausal women.
Menopause. 2010 Jul 21. [Epub ahead of print]
Dalton WT, Klesges LM, Henderson L, Somes G, Robinson L, Johnson KC. Gender, smoking
status, and risk behavior attitudes explain adolescents' patterns of nicotine replacement therapy
use. Addictive Behaviors 35 (2010) 147–151.
Schiffmann R, Martin RA, Reimschisel T, Johnson KC, Castaneda V, Lien H, Pastores GM,
Kampmann C, Ries M, Clarke JTR. Four-year prospective clinical trial of agalsidase alfa in
children with Fabry disease. J Pediatr. 2010 May;156(5):832-7, 837.e1. Epub 2010 Jan 25.
Hayes, BL, Curtis, JR, Laster, A, Saag, K, Tanner, SB, Liu, C, Womack, C, Johnson, KC, Khaliq,
F, Carbone, LD. Osteoporosis Care in the United States After Declines in Reimbursements for
DXA. J Clin Densitom, 13 (4), 352-60, 2010.
Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough
RJ, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Johnson KC, O’Sullivan MJ, Ockene
17

KC,
J, Chen C, Hubbell FA, for the Women’s Health Initiative Investigators. Oestrogen Plus Progestin
and Lung Cancer in Postmenopausal Women (Women’s Health Initiative trial): a post-hoc
analysis of a randomized controlled trial. Published online Lancet September 20 2009.
Li R, O'Sullivan MJ, Robinson J, Safford MM, Curb D, Johnson KC. Family history of myocardial
infarction predicts incident coronary heart disease in postmenopausal women with diabetes: the
Women's Health Initiative Observational Study. Diabetes Metab Res Rev. 2009 Sep 24. [Epub
ahead of print]
Atkinson HH, Rapp SR, Williamson JD, Lovato J, Absher JR, Gass M, Henderson VW, Johnson
KC, Kostis JB, Sink KM, Mouton CP, Ockene JK, Stefanick ML, Lane DS, Espeland MA. The
relationship between cognitive function and physical performance in older women: Results from
the Women's Health Initiative Memory Study. J Gerontol A Biol Sci Med Sci. 2009 Sep 29. [Epub
ahead of print]
Ix JH, Wassel CL, Chertow GM, Koster A, Johnson KC, Tylavsky FA, Cauley JA, Cummings SR,
Harris TB, Shlipak MG. Fetuin-A and Change in Body Composition in Older Adults. J Clin
Endocrinol Metab. 2009 Nov;94(11):4492-8. [Epub 2009 Oct 9].
McTiernan A, Chlebowski RT, Martin C, Peck JD, Aragaki A, Pisano ED, Wang CY, Johnson
Manson JE, Wallace RB, Vitolins MZ, Heiss G. Conjugated equine estrogen influence on
mammographic density in postmenopausal women in a substudy of the Women’s Health Initiative
Randomized Trial. J Clin Oncol. 9 November 2009. [Epub ahead of print]
Grady D, Sawaya GF, Johnson KC, Koltun W, Hess R, Vittinghoff E, Kristof M, Tagliaferri M,
Cohen I, Ensrud KE. MF101, a selective estrogen receptor A modulator for the treatment of
menopausal hot flushes: a phase II clinical trial. Menopause. 2009 May-Jun;16(3):458-65.
LaCroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, Cummings SR, Gass M, Johnson
KC, Ko M, Larson J, Manson JE, Stefanick ML, Wactawski-Wende J. Calcium plus Vitamin D
Supplementation and Mortality in Postmenopausal Women: The WHI Calcium-Vitamin D
Randomized Controlled Trial J Gerontol A Biol Sci Med Sci 2009 May;64(5):559-67. [Epub 2009
Feb 16].
Carbone LD, Johnson KC, Bush A, Robbins J, LaCroix A, Geevarghese AT, Larson J. Loop
Diuretic Use and Osteoporosis in Postmenopausal Women: Findings from the Women’s Health
Initiative (WHI). Archives Intern Med. 2009; 169(2):132-40.
Wadden TA, West DS, Neiberg R, Wing R, Ryan DH, Johnson KC, Foreyt JP, Hill JO, Trence D,
Vitolins M for the Look AHEAD Research Group. One-Year Weight Losses in the Look AHEAD
Study: Factors Associated with Success. Obesity, 2009; 17 (4): 713–722.
Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC,
Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.
Benefits and Risks of Postmenopausal Hormone Therapy When Initiated Soon After the
Menopause. Am J Epidemiol. 2009 May 25. [Epub ahead of print].
Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, Canzian F, Steplowski E,
Arslan AA, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D,
Amundadottir L, Bingham SA, Boffetta P, Boutron-Ruault M, Chanock SJ, Clipp S, Hoover RN,
Jacobs K, Johnson KC, Kooperberg C, Luo J, Messina C, Palli D, Patel AV, Riboli E, Shu X,
Suarez LR, Thomas G, Tjønneland A, Tobias GS, Tong E, Trichopoulos D, Virtamo J, Ye W, Yu
K, Zeleniuch-Jacquette A, Bas Bueno-de-Mesquita H, Stolzenberg-Solomon RZ. Cigarette
18

Smoking and Pancreatic Cancer: A Pooled Analysis From the Pancreatic Cancer Cohort
Consortium. Am J Epidemiol. 2009 June 26. [Epub ahead of print].
Ix, JH, Wassel-Fyr C, Kanaya A, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB,
Cummings SR, Shlipak MG,for the Health ABC Study. Fetuin-A and Incident Diabetes Mellitus in
Elderly Persons: The Health Aging and Body Composition (Health ABC) Study. JAMA. 2008;300
(2):182-188.
Johnson KC, Margolis KL, Espeland MA, Colenda CC, Fillit H, Manson JE, Masaki KH, Mouton
CP, Prineas R, Robinson JG, Wassertheil-Smoller S; for the Women's Health Initiative Memory
Study and Women's Health Initiative Investigators. A Prospective Study of the Effect of
Hypertension and Baseline Blood Pressure on Cognitive Decline and Dementia in
Postmenopausal Women: The Women's Health Initiative Memory Study. J Am Geriatr Soc. 2008;
56 :1449-1458].
Kaplan RC, McGinn AP, Baird A, Hendrix S, Kooperberg C, Lynch J, Rosenbaum D,
Johnson KC, Strickler H, Wassertheil-Smoller S. Inflammation and hemostasis biomarkers for
predicting risk of ischemic stroke in postmenopausal women: The Women’s Health Initiative
Observational Study. J Stroke Cerebrovasc Dis. 2008 Nov-Dec;17(6):344-55.
Allison MA, Manson J, Langer RD, Carr JJ, Rossouw JE, Pettinger, MB, Phillips L, Cochrane B,
Eaton C, Greenland P, Hendrix S, Hsia J, Hunt JR, Jackson R, Johnson KC, Kuller L., Robinson
J. Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with
hysterectomy: the Women's Health Initiative coronary artery calcium study. Menopause. 2008;15
(4): 639-642.
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T,
Rossouw J, Lane D, O’Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J,
Hubbell FA, the Women's Health Initiative Investigators. Calcium plus vitamin D supplementation
and the risk of breast cancer. J Natl Cancer Inst. 2008 Nov 11. [Epub ahead of print].
Henderson VW, Espeland MA, Hogan PE, Rapp SR, Stefanick ML, Wactawski-Wende J,
Johnson KC, Wassertheil-Smoller S, Freeman R, Curb D. Prior use of hormone therapy and
incident Alzheimer’s disease in the Women’s Health Initiative Memory Study. Neurology
2007;68: [suppl. 1]:A205.
Cui Y, Page DL, Chlebowski RT, Hsia J, Hubbell FA, Johnson KC, Rohan TE. Cigarette
Smoking and Risk of Benign Proliferative. Epithelial Disorders of the Breast in the Women's
Health Initiative. Cancer Causes Control 2007;18(4):431-438.
Wing RR, Jakicic J, Neiberg R, Lang W, Blair SN, Cooper L, Hill JO, Johnson KC, Lewis B, and
the Look AHEAD Research Group. Fitness, Fatness and Cardiovascular Risk Factors in Type 2
Diabetes: Look AHEAD Study. Med Sci Sports Exerc. 2007; 39 (12): 2107 – 2116.
Look AHEAD Research Group (writing group member Johnson KC) Reduction in Weight and
Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes: One-Year Results of
the Look AHEAD Trial. Diabetes Care. 2007; 30 (6): 1374 – 1383.
Kooperberg C, Cushman M, Hsia J, Robinson JG, Aragaki A, Lynch JK, Baird AE, Johnson KC,
Kuller L, Beresford SAA, Rodriguez B. Can biomarkers identify women at increased stroke risk:
the Women’s Health Initiative Hormone Trials. PLoS Clin Trials. 2007;2 (6): e28.
Huang A, Ettinger B, Vittinghoff E, Ensrud K, Johnson KC, Cummings S. Endogenous estrogen
levels and the effects of Ultra-Low-Dose Transdermal Estradiol therapy on bone turnover and
bone density in postmenopausal women. J Bone Miner Res. 2007;22 (11): 1791-1797.
19

Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson
JE, Sidney S, Trevisan M, for the Women’s Health Initiative Investigators. Calcium/ Vitamin D
supplementation and the risk of cardiovascular events. Circulation 2007; 115:846-854.
Abel EL, Hendrix SO, McNeeley SG, Johnson KC, Rosenberg CA, Mossavar-Rahmani Y,
Vitolins M, Kruger M. Daily Coffee Consumption and Prevalence of Nonmelanoma Skin Cancer in
Caucasian Women in the Women’s Health Initiative Observational Study. European Journal of
Cancer Prevention. Eur J Cancer Prev. 2007;16 (5): 446-452.
Iannaccone A, Mura M, Gallaher K, Johnson EJ, Todd WA, Kenyon E, Harris TL, Harris T,
Satterfield S, Johnson KC, Kritchevsky SB, for the Health ABC Study. Macular pigment optical
densitometry in the elderly. Findings in a large biracial mid-south population sample. Invest
Ophthal Vis Sci. 2007;48:1458-1465.
Gallaher KT, Mura M, Todd WA, Harris TL, Kenyon E, Harris T, Johnson KC, Satterfield S,
Kritchevsky SB, Iannaccone A for the Health ABC Study. Estimation of macular pigment optical
density in the elderly: test-retest variability and effect of optical blur in pseudophakic subjects.
Vision Research. 2007;47:1253-1259.
Klein R, Deng Y, Klein BEK, Hyman L, Seddon J, Frank RN, Wallace RB, Hendrix SL,
Kuppermann BD, Langer R, Kuller L, Brunner R, Johnson KC, Thomas AM, Haan M.
Cardiovascular disease, its risk factors and treatment and age-related macular degeneration:
Women’s Health Initiative Sight Exam Ancillary Study. Am J Ophthal. 2007; 143 (3): 473-483.
Beresford SA, Johnson KC, Ritenbaugh C, Lasser N, Snetselaar LG, Black HR, et.al. The
Women’s Health Initiative Trial of low-fat eating pattern and colorectal cancer. JAMA
2006;295:643-654.
The Women’s Health Initiative Investigators (writing group member Johnson KC). The Women’s
Health Initiative Trial of low-fat eating pattern and breast cancer. JAMA 2006;295:629-642.
The Women’s Health Initiative Investigators (writing group member Johnson KC). The Women’s
Health Initiative Trial of low-fat eating pattern and cardiovascular disease. JAMA 2006;295:655-
666.
The Women’s Health Initiative Investigators (writing group member Johnson KC). The Women’s
Health Initiative Trial of calcium plus vitamin D supplementation on the risk for fractures. N Engl J
Med. 2006;354:669-683.
The Women’s Health Initiative Investigators (writing group member Johnson KC). Calcium plus
vitamin D supplementation and colorectal cancer in postmenopausal women: The Women’s
Health Initiative Clinical Trial. N Engl J Med 2006;354:684-696.
Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR,
Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R for the Women’s Health
Initiative Investigators. Conjugated equine estrogen and coronary heart disease: the Women’s
Health Initiative. Arch Intern Med 2006;166:357-365.
Hendrix S, Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M,
Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Mouton C, Rapp
SR, Torner J for the WHI Investigators. Effects of Conjugated Equine Estrogen on Stroke in the
Women’s Health Initiative. Circulation 2006;113:2425-2434.
20

Bonds D, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC,
Margolis KL. Increased Risk of Fracture among Women with Type 2 Diabetes: the Women’s
Health Initiative Observational Study. J Clin Endocrinol Metab 2006;91(9):3404-3410.
Pradhan AD, Manson JE, Hendrix S, Johnson KC, Wagenknecht LE, Haan MN, Weidner G,
LaCroix, AX, Cook NR. Cross-sectional correlates of fasting hyperinsulinemia post-menopausal
women of different ethnic origin. Diabet Med. 2006;23:77-85.
Maraldi C, Volpato S, Kritchevsky SB, Cesari M, Andresen E, Leeuwenburgh C, Harris TB,
Newman AB, Kanaya A, Johnson KC, Rodondi N, Pahor M. Alcohol Consumption, Mortality and
Cardiac Events: Impact of Inflammation. The Health, Aging, and Body Composition Study. Arch
Intern Med. 2006;166:1490-1497.
Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D Effects of ultra lowdose
transdermal estradiol on cognitive function and health related quality of life. Arch Neurol
2006;63:945-950.
Farhat G, Strotmeyer, Newman AB, Sutton-Tyrrell K, Bauer D, Harris T, Johnson KC, Taaffe D,
Tylavsky F, Cauley JA. Volumetric and areal bone mineral density measures are associated with
cardiovascular disease in older men and women: The Health Aging and Body Composition Study
(Health ABC). Calcified Tissue International. 2006;79:102-111.
Klesges RC, Johnson KC, Somes G. Varenicline for smoking cessation: definite promise but no
panacea. JAMA 2006;296:94-95.
Koster A, Bosma H, Penninx WJH, Newman AB, Harris TB, van Eijk J, Kempen G, Simonsick
EM, Johnson KC, Rooks RN, Ayonayon HN, Rubin SM, Kritchevsky SB for the Health ABC
Investigators. Association of inflammatory markers with socio-economic status. J Gerontology:
Medical Sciences. 2006; 61A: 284-290.
The Look AHEAD Research Group (Writing group member Johnson KC). Baseline
characteristics of the randomized cohort from the Look AHEAD (Action for Health in Diabetes)
Research Study. Diabetes and Vascular Disease Research 3:202-215, 2006.
McTiernan A, Martin C, Peck J, Agagaki A, Chlebowski R, Pisano E, Wang CY, Brunner R,
Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka B for the Women’s Health Initiative
Mammogram Density Study Investigators. Estrogen plus progestin influence on mammogram
density in healthy postmenopausal women in the Women’s Health Intiative Randomized Trial.
J Natl Cancer Inst. 2005;97:1366-1376.
Cooper TV, Klesges RC, Debon MW, Zbikowski SM, Johnson KC, Clemens LH. A placebo
controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation
rates and postcessation weight gain in women. Addictive Behaviors. 2005; 30:61-75.
The Women’s Health Initiative Steering Committee (writing group member Johnson, KC).
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the
Women’s Health Initiative Randomized Controlled Trial. JAMA. 2004;291:1701-1712.
Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR Yanknov V, Vittinghoff E, Grady
D. Effects of ultralow-dose trandermal estradiol on bone mineral density: results of a
randomized clinical trial. Obstet Gyncol. 2004;104:443-451.
Women’s Health Initiative Study Group (writing group member Johnson KC). Dietary adherence
in the Women’s Health Initiative Dietary Modification Trial. J Am Diet Assoc.2004;104:654-658.
21

Cooper TV, DeBon MW, Stockton M, Klesges RC, Steenbergh TA, Sherill-Mittleman, Jennings L,
Johnson KC. Correlates of adherence with transdermal nicotine. Addictive Behaviors.
2004;29:1565-1578.
Johnson KC, Klesges LM, Somes G, Coday M, DeBon M. Access of over-the-counter nicotine
replacement therapy products to minors. Arch Pediatr Adolesc Med. 2004;158:212-216.
The Look AHEAD Research Group (writing group member Johnson, KC). Look AHEAD: Action
for Health in Diabetes: Design and methods for a clinical trial of weight loss for the prevention of
cardiovascular disease in type 2 diabetes. Controlled Clinical Trials. 2003;24: 610-628.
Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR,
Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M. Estrogen
plus progestin and risk of coronary heart disease: final results from the Women’s Health Initiative.
N Engl J Med 2003;349:523-534.
Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML,
Stefanick ML, Lane DL, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D for the WHIMS
Investigators. Effect of estrogen plus progestin on global cognitive function in postmenopausal
women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA.
2003;289:2663-2672.
Klesges LK, Johnson KC, Somes G, Zbikowski S, Robinson L. Nicotine replacement therapy
use in adolescent smokers and nonsmokers. Arch Pediatr Adolesc Med. 2003;157:517-522.
Curb D, McTiernan A, Heckbert SR, Koopersberg C, Stanford J, Nevitt M, Johnson KC, Proux-
Burns L, Pastore L, Criqui M, Daugherty S. Outcomes ascertainment and adjudication in the
Women’s Health Initiative. Ann Epidemiol. 2003;13 (9s):122-128.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperburg C, Stefanick ML, Jackson RD,
Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women’s
Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy
postmenopausal women: principal results from the Women’s Health Initiative randomized
controlled trial. JAMA. 2002;288:321-333.
WHI Steering Committee and the Writing Group (Johnson KC). Risks of postmenopausal
hormone replacement response to letters to the editor. JAMA. 2002;288:2823-2824.
Rogers LQ, Bailey JE, Gutin B, Johnson KC, Levine MA, Milan F, Seeling CB, Sherman SE.
Teaching physicians in training to provide exercise counseling: a needs assessment. Acad Med.
2002;77:841-844.
Coday M, Klesges LM, Garrison RJ, Johnson KC, O’Toole M, Morris GS. Health opportunities
with physical exercise (HOPE): social contextual interventions to reduce sedentary behavior in
urban settings. Health Education Research: Theory and Practice. 2002;17:101-111.
Kostis JB, Wilson AC, Hooper WC, Harrison KW, Philipp CS, Appel LJ, Espeland M, Folmar S,
Johnson KC, for the TONE Cooperative Research Group. Associations with ACE (DD)
genotypes with blood pressure sensitivity to weight loss. Am Heart J. 2002;144:625-629.
Pahor M, Franse LV, Deitcher SR, Cushman WC, Johnson KC, Shorr RI, Kottke-Marchant K,
Tracy RP, Somes GW, Applegate WB. Fosinopril versus amlodipine comparative treatments
study: a randomized trial to assess effects on plasminogen activator inhibitor-1. Circulation.
2002;105:457-461.
22

Manson JE, Lewis CE, Kotchen JM, Allen C, Johnson KC, Stefanick M, Foreyt J, Klesges RC,
Tinker L, Noonan L, Perri M, Hall D. Ethnic, socioeconomic, and lifestyle correlates of obesity in
U.S. women: the Women’s Health Initiative. Clinical Journal of Women’s Health. 2001;1:225-
234.
Johnson KC. Hormone replacement therapy and cardiovascular disease. The Female Patient.
October 2001.
Hall WD, Pettigner M, Oberman A, Watts NB, Johnson KC, Paskett Ed, Limacher MC, Hayes J.
Risk factors for kidney stones in older women in the southern United Sates. Am J Med Sci
2001;322 (1): 1-7.
Klesges LM, Johnson KC, Ward KD, Barnard M. Smoking cessation in pregnant women.
Obstetrics and Gynecology Clinics in North America. 2001;28:269-282.
The Writing Group for the Activity Counseling Trial Research Group (Investigator-Johnson KC).
Effects of physical activity counseling in primary care. JAMA. 2001;286:677-687.
Johnson KC, Clarke C, Shorr RI, Mauck C, Summitt RL, Applegate WB. Will women accept
randomization in a clinical trial of hormonal contraceptives? Clinical Journal of Women’s Health.
2000;1:16-22.
O’Toole M, Johnson KC, Satterfield S, Bush A, Koo W, Klesges RC, Applegate WB. Do sweat
calcium losses affect bone mass during firefighter training? J Occup Environ Med.
2000;42:1054-1059.
Shorr RI, Resnik HE, Franse LV, DiBari M, Johnson KC, Pahor M. Glycemic control of older
adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination
Survey, 1988-1994. J Am Geriatric Soc 2000;48:264-267.
Bullen DB, O'Toole ML, Johnson KC. Calcium losses resulting from an acute bout of moderate
intensity exercise. International Journal of Sport Nutrition. 1999;9:275-284.
Johnson KC, Graney MJ, Applegate WB, Kitabchi AE, Runyan JW, Rutan GH. Does syndrome
-X exist in hypertensive elderly persons with impaired glycemic control? J Geron Med Sciences.
1999;54A:571-576.
Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, et.al. for the
WHIMS Investigators (Investigator -Johnson KC). The Women's Health Initiative Memory Study
(WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of
dementia. Controlled Clinical Trials. 1998;19:604-621.
Kostis JB, Espeland M, Appel L, Johnson KC, Pierce J, Wofford J. Does withdrawal of
antihypertensive medication increase the risk of cardiovascular events? Results from the trial of
nonpharmacologic interventions in the elderly (TONE). Am J Cardiol. 1998;82:1501-1508.
Whelton PK, Appel L, Espeland MA, Ettinger W, Kostis JB, Kumanyika S, Lacy CR, Johnson
KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in
older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly
(TONE). JAMA. 1998;279:839-846.
HERS Research Group (Investigator - Johnson KC). Randomized trial of estrogen plus
progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA.
1998;280:605-613.
23

Shorr RI, Johnson KC, Wan JY, Sutton-Tyrrell K, Pahor M, Bailey JE, Applegate WB. The
prognostic significance of asymptomatic carotic bruits in the elderly: findings from SHEP. J Gen
Int Med 1998;13:86-90.
Tylavsky FA, Johnson KC, Wan JY, Harshfield G. Plasma renin activity is associated with bone
mineral density in premenopausal women. Osteoporos Int 1998;8:136-140.
Johnson KC, Graney MJ, Applegate WB, Kitabchi AE, Runyan JW, Shorr RI. Prevalence of
undiagnosed noninsulin dependent diabetes mellitus and impaired glucose tolerance in a cohort
of older persons with hypertension. J Am Geriatric Soc 1997;45:695-700.
Ginsberg JP, Klesges RC, Johnson KC, Eck LH, Meyers AW, Winders SA. The relationship
between a history of depression and adherence to a multicomponent smoking cessation
program. Addictive Behaviors 1997;22:1-5.
Richey PA, Jones CL, Harshfield GA, Somes GW, Johnson KC, Bailey JE, Soberman JE. The
AM5600 ambulatory blood pressure recording system. Blood Pressure Monitoring 1997;2:193-
195.
Rogers LQ, Johnson KC, Young ZM, Graney M. Demographic bias in physician smoking
cessation counseling. Am J Medical Sciences 1997;313:153-158.
Harshfield GA, Somes GW, Richey PA, Pulliam DA, Jones CL, Johnson KC. Renin/sodium
relationships in salt sensitive subjects. Am J Hyperten 1995:8159A.
Johnson KC. Smoking cessation and the doctor's office. J Tenn Med Assoc 1995;88:145 -146.
April 1995.
Johnson KC, Ford D, Smith G. An evaluation of the current practices of internists in residential
fire injury prevention. Am J Prev Med 1993;9:39-44.
Rogers LQ, Johnson KC, Areheart KL. Current physician screening and treatment of
hypercholesterolemic patients. Am J Med Science 1993;306:124-128.
Smith WR, Johnson KC, Jackson W. Developing a computerized ambulatory medical record
system to enhance health promotion and disease prevention. J Ambulatory Care Manage.
1992;215:9-17.
Johnson KC, Joe RH, Self TH. Ciprofloxacin and warfarin interaction, a letter to the editor.
Journal of Family Practice. 1991;33:338.
Henkin Y, Johnson KC, Segrest JP. Rechallenge with crystalline niacin after drug induced
hepatitis from sustained released niacin. JAMA. 1990;264:241-243.
Publications (Journals - Submitted under Review)
Neuhouser ML, Di C, Tinker LF, Thomson C, Sternfeld B, Mossavar-Rahmani Y, Stefanick ML,
Sims S, Curb JD, Lamonte M, Seguin R, Johnson KC, Prentice RL. Physical Activity
Assessment: Biomarkers and Self-Report of Activity-Related Energy Expenditure in the Women’s
Health Initiative. Submitted 2012.
24

Kroenke CH, Stefanick ML, Wallace R, La Croix AZ, LeBlanc E, Park HL, Anderson G, Brzyski R,
Johnson KC, Sims ST, Lee C, Vitolins M, Caan BJ. Effects of a dietary intervention and weight
change on vasomotor symptoms in the Women’s Health Initiative. Submitted 2011.
Simon MS, Chlebowski, RT, Wactawski-Wende, J, Johnson, KC, Muskovitz A, Kato I, Young A,
Hubbell FA, Prentice RL. Oestrogen plus Progestin and Colorectal Cancer Incidence and
Mortality. Submitted 2011.
Chen J, Espeland MA, Brunner RL, Lovato LC, Wallace RB, Leng X, Phillips LS, Robinson JG,
Kotchen JM, Johnson KC, Manson JE, Stefanick ML, Sarto GE, Mysiw WJ. Sleep Duration,
Cognitive Function, and Neurocognitive Impairment in Older Women. Submitted 2011.
Publications (Book Chapters)
Johnson KC. Hormone Replacement and Cardiovascular Disease. In Lobo RA, ed. Women’s
Health and Menopause: New Strategies-Improved Quality of Life. London: Kluwer Academic
Publishers; 2002: 143-149.
Koster A, Bosma H, Penninx BW, Newman AB, Harris TB, van Eijk JT, Kempen GI, Simonsick
EM, Johnson KC, Rooks RN, Ayonayon HN, Rubin SM, Kritchevsky SB. Association of
inflammatory markers with socioeconomic status. In Socioeconomic Health Differences in Old
Age: Unraveling the Role of biomedical, Behavioral, and Psychosocial Factors. PrintPartners
Ipskamp, Enschede 2005: 65-80.
Publications (Position Papers)
Johnson KC, Chin L, Mickalide AD. A Review of the State of Medical Education on Prevention.
Position paper for the Office of Disease Prevention and Health Promotion, Public Health Service,
Department of Health and Human Services. Presented at the U.S. Preventive Services
Coordinating Committee Meeting, February, 1990.
Johnson KC, Mickalide AD. A Review of the State of Allied Health Education on Prevention.
Position paper for the Office of Disease Prevention and Health Promotion, Public Health Service,
Department of Health and Human Services. Presented at the U.S. Preventive Services
Coordinating Committee Meeting, February, 1990.
Johnson KC, Manley M. Smoking Prevention and Cessation: A National Priority for Medical
Education. Position paper for the National Cancer Institute, National Institutes of Health, 1989.
Johnson KC, Mickalide AD. Public Health Service (PHS) Position Statement on the US
Preventive Services Task Force Recommendations on Preventive Dentistry. Office of Disease
Prevention and Health Promotion, Public Health Service, Department of Health and Human
Services, 1989.
Publications (Manuals)
Manual of Operations for A Clinical Trial of Two Medications on Smoking Cessation (STAR).
Funded by the National Heart, Lung, and Blood Institute, NIH, 2002.
Manual of Operations for The Use of Sibutramine in Smoking Cessation Study (SUCCESS).
Funded by the National Heart, Lung, and Blood Institute, NIH, 2001.
Adverse Event Chapter for the Manual of Operations for the Look AHEAD Study. Funded by the
National Institute on Diabetes, Digestive Disorders, and Kidney Disease, NIH, 2001
25

Manual of Operations for the Research on the Effect of the Nicotine Patch in Expectant Women
Study (RENEW). Funded by the National Institute on Drug Abuse, NIH, 1998.
Manual of Operations for the Contraceptive Hormone Assessment of Risk Markers Study
(CHARM). Funded by the National Institute of Child Health and Human Development, NIH, 1993.
Presentations with Published Abstracts
Bertoia ML, Allison M, Manson JE, Freiberg MS, Kuller LH, Solomon AJ, Limacher MC, Johnson
KC, Curb JD, Wassertheil-Smoller S, Eaton CB. Risk Factors for Sudden Cardiac Death in Post-
Menopausal Women. American Heart Association EPI NPAM conference, 2011.
Goss PE, Ingle JN, Ales-Martinez J, Cheung A, Chlebowski RT, Wactawski-Wende J, McTiernan
A, Robbins J, Johnson KC, Martin L, Winquist E, Sarto G, Garber JE, Fabian CJ, Pujol P,
Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H. NCIC CTG MAP.3: a phase III placebocontrolled
Breast Cancer Prevention Trial of exemestane in postmenopausal women at risk for
breast cancer. American Society of Clinical Oncology. 2011
Tindle HA, Chang Y, Kuller LH, Shiffman S, Schmidhofer M, Liu S, Howard B, Womack C, Curb
JD, Johnson KC, Martin LW, Eaton CB, Safford M, Li W, Freiberg MS. The Major Impact of
Smoking on Mortality in Postmenopausal Women. Abstract. 23rd Annual Scientific Retreat of the
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, June 2011.
Doyle T, de Groot M, Harris T, Schwartz F, Strotmeyer ES, Johnson KC, Kanaya A M, Maraldi
C. Diabetes, depression, and inflammation in older adults: Results from the Health, Aging, and
Body Composition Study (Health ABC Study. Diabetes, 59 (S1A), LB-123, 2010.
Watson NL, Sutton-Tyrrell K, Mackey RH, Brach JS, Najjar S, Venkitachalam L, Bauer DC,
Rodondi N, Johnson KC, Simonsick E, Newman AB for the Health ABC Study. Subclinical
Cardiovascular Disease and Gait Speed in Well-Functioning Older Adults. AHA Cardiovascular
Disease Epidemiology and Prevention Conference. March 2009
Spangler EL, Watson NL, Venkitachalam L, Sutton-Tyrrell K, Simonsick EM, Najjar SS, Brach JS,
Mackey RH, Bauer DC, Rodondi N, Johnson KC, Newman AB for the Health ABC study. Arterial
Stiffness and Walking Endurance in Community-Dwelling Older Adults. AHA Cardiovascular
Disease Epidemiology and Prevention Conference. March 2009.
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T,
Rossouw J, Lane D, O’Sullivan MJ, Hubbell FA. Calcium plus Vitamin D Supplement use, 25-
Hydroxyvitamin D (25 OHD) levels and breast cancer risk in the Women’s Health Initiative (WHI).
Presented at the American Society of Clinical Oncologist. 2008.
DeBon M, Johnson KC, Bush A, and Klesges RC. (2008, March). The efficacy of sibutramine to prevent
or decrease post cessation weight gain in overweight and obese smokers. Paper presented at the 29 th
annual meeting of the Society of Behavioral Medicine, San Diego, CA. March 2008.
Atkinson HH, Williamson JD, Rapp SR, Lovato J, Sink KM, Absher JR, Gass M, Henderson V,
Johnson KC, Kostis JB, Mouton C, Ockene JK, Stefanick M, Lane DS, Espeland MA. Grip
strength predicts dementia beyond baseline global cognitive function in older women: The
Women’s Health Initiative Memory Study (WHIMS). American Geriatircs Society. 2007.
Allison MA, Manson J, Langer RD, Carr JJ, RossouwJE, Phillips L, Cochrane B, Eaton C,
Greenland P, Hendrix S, Hunt JR, Jackson R, Johnson KC, Kuller L, Robinson J. History of
26

Oophorectomy is Associated with Higher Risk of Subclinical Coronary Artery Disease in Women
with Hysterectomy. American Heart Association Conference on Cardiovascular Disease
Epidemiology and Prevention. Orlando, FLA, March 2007.
Beresford SA, Johnson KC, Ritenbaugh C, Lasser N, Snetselaar LG, Black HR, et.al. Low fat
eating pattern intervention and risk of colorectal cancer in postmenopausal women: the WHI
randomized controlled dietary modification trial. American Public Health Association. Boston,
MA.. November, 2006.
Chlebawski RT, Johnson KC, Kooperberg C, Hubbell FA, Lane D, O’Sullivan M, Cummings S,
Hiatt R, Shikany JM, Rohan T, Yasmeen S, Khandekar J for the Women’s Health Initiative
Investigators. The Women’s Health Initiative randomized trial of calcium plus vitamin D: Breast
cancer and arthralgia effects. American Society for Clinical Oncologist. June 2006.
Kooperberg C, Cushman M, Robinson JG, Aragaki A, Baird A, Beresfor SA A, Hsia J, Johnson
KC, Kuller L, Rodriguez B. Inflammation and thrombosis biomarkers, risk of ischemic stroke and
interactions with hormone treatment in postmenopausal women. American Heart Association
March 2006, published in Circulation 2006;113:e312.
Maraldi C, Andresen E, Harris T, Kanaya A, Johnson KC, Kritchevsky S, Newman A, Volpato S,
Leeuwenburgh C, Cesari M, Rodondi N. Alcohol intake, mortality and inflammation among older
people. The Health, Aging and Body Composition (Health-ABC) Study. American Geriatrics
Society. 2006.
Iannaccone A, Gallaher K, Mura M, Kenyon E, Harris TL, Todd WA, Johnson KC, Satterfield S,
Kritchevsky SB. Macular pigment optical densitometry in the elderly: Findings in a large biracial
mid-south sample and effect of optical blur in pseudophakic subjects. Association for Research
in Vision and Ophthalmology, 2005
Gallaher K, Mura M, Todd WA, Kenyon E, Harris TL, Satterfield S, Harris T, Johnson KC,
Kritchevsky SB, Iannaccone A. Test-retest variability of macular pigment optical densitometry in
the elderly: Findings from the Health ABC ARMA Study. Association for Research in Vision and
Ophthalmology, 2005
Langer RD, Hsia J, Pettinger M, Caralis P, Crawford S, Eaton CB, Greep N, Heckbert SR,
Hendrix S, Kostis J, Kuller L, Johnson KC, Manson JE, Cojugated equine estrogen-alone and
risk of coronary heart disease: results of the Women’s Health Initiative Clinical Trial. American
Heart Association. New Orleans, 2004.
Farhat GN, Strotmeyer ES, Newman AB, Sutton-Tyrrell K, Bauer DC, Harris T, Johnson KC,
Taaffe D, Cauley JA for the Health ABC Study. American Society for Bone Mineral Research.
2004.
Rogers LQ, Johnson KC. Patient follow-up during clinical trials in an inner city population:
problems and solutions. Prevention 95. New Orleans, LA. March, 1995.
Rogers LQ, Johnson KC, Arheart KL. Current physician screening and treatment of
hypercholesterolemic patients. Society of General Internal Medicine, Meeting of the Southern
Section. New Orleans, LA. January, 1993.
Johnson KC. Secondary causes of hypertension in women. 18th Southeast Conference on High
Blood Pressure sponsored by the National High Blood Pressure Education Program, National
Heart, Lung, and Blood Institute, National Institutes of Health. Memphis, TN April, 1993.
27

Johnson KC, Ford D, Smith G. Evaluating the role of the physician in residential fire injury
prevention. Society of General Internal Medicine, Southeastern Regional Meeting, New Orleans,
LA. February, 1991.
Johnson KC, Ford D, Smith G. Prevention of residential fire deaths in a general medicine clinic.
Society of General Internal Medicine, National Meeting, Washington, DC. May, 1990.
Johnson KC, Ford D, Smith G. prevention of residential fire deaths in a general medicine clinic.
Society of General Internal Medicine, Mid-Atlantic Regional Meeting, Philadelphia, PA. February,
1990.
Posters with Published Abstracts
Doyle, T, de Groot, M, Harris, T, Schwartz, F, Strotmeyer, E S, Johnson, KC, Kanaya, A M,
Maraldi, C. Diabetes, Depression, and Inflammation in Older Adults: Results from the Health,
Aging, and Body Composition Study. American Diabetes Association Meeting. Orlando, FL, June,
2010.
McTigue KM, Lewis C, Valoski A, Kuller L, Johnson KC, Robinson J, Garcia L, Siminliu, Eaton C
Milagros R. Adding weight status to cardiovascular risk factor presence in 50-59 year old women
can help delineate coronary heart disease risk in white and black women. 48 th Cardiovascular
Disease Epidemiology and Prevention Annual Conference, American Heart Association Meeting.
March 2008.
Coday M, Bush A, Johnson KC, Klesges L. Fitness, physical activity, weight, and stress:
Results from the HOPE trial. International Society for Behavioral Nutrition and Physical Activity,
7th Annual Meeting, Oslo, June 2007.
Williams C, Hogan P, Barnes J, Feeney P, Lewis C, Johnson KC, and the Look AHEAD
Research Group. A web-based approach to adjuciation management in a clinical trial. Society for
Clinical Trials. 2007.
Henderson V, Hogan S, Rapp S, Stefanick M, Wactawski-Wende, J, Johnson KC, Wassertheil-
Smoller S, Freeman S, Curb D. Prior use of hormone therapy and incident Alzheimer’s disease in
the Women’s Health Initiative Memory Study. Am. Academy of Neurology, Boston, MA, 2007.
Wing R, Wadden T, West D, Neiberg R, Trence D, Hill J, Johnson KC, Ryan D, Vitolins M,
Foreyt J, and the Look AHEAD Study Group. Factors Associated with weight loss success in
Look AHEAD’s Intensive Lifestyle Intervention. NAASO, 2007.
Kooperberg C, Cushman M, Robinson JG, Aragaki A, Baird A, Beresford SAA, Hsai J, Johnson
KC, Kuller L, Rodriguez B. Inflammation and thrombosis biomarkers, risk of ischemic stroke, and
interactions with hormone treatment in postmenopausal women. American Heart Association
Annual Conference on Cardiovascular Diseases, Epidemiology and Prevention. Tuscon, AZ,
2006.
Henderson LE, Klesges LM, Johnson KC, DeBon M, Somes G, Stotts C.. Use of nicotine
replacement therapy among adolescents is related to gender, smoking status, and risk behavior
attitudes. Society of Behavioral Medicine, Boston, MA, 2005.
Klesges LM, DeBon M, Johnson KC, Klesges RC, Vander Weg MW, Relyea GE. Inappropiate
use of nicotine replacement therapy (NRT) related to age at first use and risk behavior attitudes
in U.S. Air Force recruits. American College of Epidemiology, New Orleans, LA, 2005.
28

Li R, Johnson KC, O’Sullivan MJ, Robinson J, Safford M, Curb D. Macrovascular complications
of diabetes associated with family history of cardiovascular diseases in the Women’s Health
Initiative Observational Study. American Diabetes Association. San Diego, CA, 2005.
McTiernan A, Martin C, Peck J,Aragaki A, Chlebowski R, Pisano E, Wang CY, Brunner R,
Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka B for the Women’s Health Initiative
Mammogram Demsity Study Investigators. Frontiers in Cancer Research Prevention Meeting.
2004.
Cummings SR, Yankov V, Ensurd K, Ettinger BE, Wallace R, Johnson KC, Meacer J, Vittinghoff
E, Grady D. Ultralow estradiol increases BMD and decreases bone turnover in older women,
particularly those with undetectable estradiol: The Ultra Trial. American Society for Bone and
Mineral Research Meeting, Minneapolis, MN, 2003.
Hsia J, Manson JE, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR,
Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M. Estrogen
plus progestin and coronary heart disease risk: final results from the Women’s Health Initiative.
American Heart Association Meeting Orlando, FL 2003.
Brown CS, Ling F, Johnson KC, Vogt V, Glazer H, Wan J.. Predictors of treatment response in
a self-report survey of vulvodynia patients. American College of Obstetricians and
Gynecologists’ 51st Annual Clinical Meeting. New Orleans LA. 2003
Stockton M, DeBon MW, Sherill-Mittlemen D, Klesges RC, Steenbergh T, Johnson KC.
Physician versus patient recall of physician-delivered smoking cessation advice. Society for
Research on Nicotine and Tobacco. 2003.
Cooper, TV, DeBon MW, Zbikowski S, Klesges RC, Johnson KC. A placebo controlled
randomized trial of the effects of PPA and nicotine gum on cessation rates and postcessation
weight gain in women. Society for Research on Nicotine and Tobacco. 2003
Coday M, King A, Somes G, Marcus B, Smith H, Voorhees C, Cohen S, Johnson KC, Albright C.
Assessment of smoking status and its relationship to changes in fitness, physical activity, and
physical activity motivation. Society for Research on Nicotine and Tobacco. 2002
Klesges LM, Johnson KC, DeBon M, Klesges RC. Nicotine replacement therapy use in U.S. Air
Force military recruits. Society for Research on Nicotine and Tobacco. 2001.
Wilson AC, Kostis JB, Philipp CS, Appel LJ, Espeland M, Johnson KC, Cutler JA, Hooper WC.
ACE gene (DD) genotype is associated with response to dietary weight loss therapy of
hypertension: effect of race and sex. International Society of Hypertension. Chicago, 2000.
Wilson AC, Kostis JB, Philipp CS, Appel LJ, Espeland M, Folmar S, Johnson KC, Cutler JA,
Hooper WC for the TONE Collaborative Research Group. Blood pressure sensitivity to weight
loss in elderly white hypertensives: Association with ACE (DD) genotype. American Society of
Hypertension. New York, 2000.
Coday M, Johnson KC, Klesges RB, King A, Albright C, Hogan P, Rejeski J, Cohen S, Marcus
B, Sallis J, Voorhees C. Smoking status and ability to initiate a program of physical activity.
Society for Research on Nicotine and Tobacco. San Diego, 1999.
Johnson KC, Graney MJ, Applegate WB, Kitabchi AE, Runyan JW. Does Syndrome X exist in
hypertensive elderly persons with impaired glycemic control? Society of General Internal
Medicine Regional Meeting. New Orleans, 1999.
29

MacDonald B for the Idoxifene Study Group (Johnson KC). Idoxifene has beneficial effects on
bone and lipid metabolism without producing estrogenic changes in endometrial histology. 1999.
Bullen DB, O'Toole ML, Johnson KC. Calcium losses resulting from an acute bout of moderate
intensity exercise. American College of Sports Medicine for 1998 meeting. Orlando, FL. June,
1998.
Johnson KC, Klesges LM, Somes G, Coday M. Availability of over-the counter nicotine
replacement therapy products to minors. Society for Research on Nicotine and Tobacco for 1998
meeting. New Orleans, LA. March, 1998.
Rogers LQ, Johnson KC, Mobley JA. Determinants of resident treatment of
hypercholesterolemic patients. Society of General Internal Medicine National Meeting.
Washington, DC. May, 1997.
Somes GW, Harshfield Ga, Jones CL, Richey PA, Johnson KC, Soberman JA, Bailey JE.
Reliability of 24-hour renin and blood pressure responses to a low salt diet. American Society of
Hypertension Scientific Meeting. New York, NY. May, 1997.
Rogers LQ, Johnson KC, Mobley JA. Inner-city patients with hypercholesterolemia: attitudes
toward a low fat diet. Prevention 96: meeting of the American College of Preventive Medicine.
Dallas, TX. March, 1996.
Somes GW, Harshfield GA, Richey PA, Jones CL, Johnson KC, Bailey JE. Renal function
curves over 24-hours in healthy older individuals. Scientific meeting of the American Society of
Hypertension. New York, NY. May, 1996.
Harshfield GA, Somes GW, Richey PA, Jones CL, Johnson KC, Bailey JE. The RAAS and
blood pressure regulation over 24-hours in healthy older individuals. Scientific meeting of the
American Society of Hypertension. New York, NY. May, 1996.
Richey PA, Jones CL, Harshfield GA, Somes GW, Johnson KC, Bailey JE. Accuracy/
performance of the AM5600 ambulatory blood pressure recorder. Scientific meeting of the
International Society of Hypertension. Glasgow, UK. June, 1996.
Somes GW, Harshfield GA, Richey PA, Jones CL, Johnson KC, Bailey JE. Salt restriction alters
24-hour pattern of PRA but not PAC. Scientific meeting of the International Society of
Hypertension. Glasgow, UK. June, 1996.
Somes GW, Harshfield GA, Richey PA, Jones CL, Johnson KC, Bailey JE. Diet influences
relationship of 24-hour patterns of PRA and PAC. Scientific meeting of the International Society
of Hypertension. Glasgow, UK. June, 1996.
Harshfield GA, Somes GW, Richey PA, Jones CL, Johnson KC, Bailey JE. Salt restriction alters
the ambulatory blood pressure profile in some but not all subjects. Scientific meeting of the
International Society of Hypertension. Glasgow, UK. June 1996.
Somes GW, Harshfield GA, Richey PA, Pulliam DA, Jones CL, Johnson KC. The reninangiotensin-aldosterone
system and salt sensitivity in elderly. American Society of Hypertension
Scientific Meeting. New York, NY. May, 1995.
Harshfield GA, Somes GW, Richey PA, Pulliam DA, Jones CL, Johnson KC. Renin/sodium
relationship in salt sensitive subjects. American Society of Hypertension Scientific Meeting. New
York, NY. May, 1995.
30

Harshfield GA, Somes GW, Richey PA, Pulliam DA, Jones CL, Johnson KC. Salt sensitivity and
the uncoupling of the RAAS. American Society of Hypertension Scientific Meeting. New York,
NY. May, 1995.
Rogers LQ, Johnson KC, Arheart KL. Resident knowledge and utilization of NCEP guidelines.
Society of General Internal Medicine National Meeting. Washington, DC. May, 1993.
Published Abstracts
Haines JL, Spencer K, Olson LM, Agarwal A, Postel EA, Iannaccone A, Satterfield S, Johnson
KC, Kritchevsky SB, Pericak-Vance MA. Progress in Predicting Risk for Age-Related Macular
Degeneration. AVRO 2009.
Manson J, Lewis C, Kotchen J, Allen C, Johnson KC, Stefanick M, Foyeyt J, Klesges R, Tinker
L, Noonan E, Perri M, Hall D. Ethnic, socioeconomic, and lifestyle correlates of obesity in U.S.
Women: the Women’s Health Initiative. Epidemiology Congress. 2001.
Klesges LM, Johnson KC, DeBon M, Klesges R. Nicotine replacement therapy use in U.S. Air
Force military recruits. Epidemiology Congress. 2001.
Jenkins PH, Riely CA,Bailey JE, Johnson KC. An outbreak of hepatitis in workers at a toxic
waste recycling plant. 52nd Annual Meeting and Postgraduate Course. American Association for
the Study of Liver Diseases Annual Meeting. Dallas, TX, November 2001 Hepatology, October
2001 suppl.
Wilson AC, Kostis JB, Philipp CS, Appel LJ, Espeland M, Folmar S, Johnson KC, Cutler JA
Hooper WC. Blood pressure sensitivity to weight loss in elderly white hypertensives: association
with ACE (DD) genotype. American Society of Hypertension, 2000.
Kostis JB, Philipp CS, Appel LJ, Espeland MA, Johnson KC, Hooper WC. ACE gene (DD)
genotype is associated with response to dietary weight loss therapy of hypertension: effect of
race and sex. International Society o Hypertension, 2000.
Shorr RI, Pahor M, Johnson KC, Wan J, Applegate WB. Does moderate alcohol use reduce the
effectiveness of hypertension treatment? Society of General Internal Medicine. 1997.
Johnson KC, Rogers LQ, Mobley JA. Barriers to successful physician smoking cessation
counseling. Society of General Internal Medicine. 1996.
Crouse JR, Davis K, Thomas MJ, Fleming RA, Holmes RP, Terry JG, Garg R, Johnson KC,
Hunninghake DB, Sheps D. Validity of intermediary markers of antioxidant status in a multicenter
trial. American Heart Association 1996.
Rogers LQ, Johnson KC, Arheart KL. Current physician screening and treatment of
hypercholesterolemic patients. Clinical Research 1993;40:811A.
Rogers LQ, Johnson KC. Resident knowledge and utilization of NCEP guideline. Clinical
Research (April, 1993).
Johnson KC, Rogers LQ. Gender bias in physician smoking cessation counseling. Clinical
Research (April 1993).
Stephens MA, Rogers LQ, Johnson KC, Fulbright V. Evaluation of a cost-containment program
in hypertensive patients prescribed sustained released Nifedipine. Clinical
Research (April, 1993)
31

COMMITTEES AND OFFICES HELD
Department of Preventive Medicine Committee Appointments
Medical Director for the 2 Preventive Medicine Research Clinics. 1995 – present.
Search Committee for Tenure Track Behavioral Epidemiologist Position in the Department of
Preventive Medicine, College of Medicine, University of Tennessee, Memphis. 2003.
Search Committee for Tenure Track Physician Epidemiologist Position in the Department of
Preventive Medicine, College of Medicine, University of Tennessee, Memphis. Chairman. 2002.
Search Committee for Tenure Track Genetic Epidemiologist Position in the Department of
Preventive Medicine, College of Medicine, University of Tennessee, Memphis. Chairman. 2000.
Search Committee for Tenure Track Physician Epidemiologist Position in the Department of
Preventive Medicine, College of Medicine, University of Tennessee, Memphis. Chairman. 1999.
Search Committee for Associate Professor Position in the Department of Preventive Medicine,
College of Medicine, University of Tennessee, Memphis. Chairman. 1996.
Study Group on the Masters of Science Program in Epidemiology, College of Medicine,
University of Tennessee, Memphis. Member. 1995 - 1996.
College of Medicine Committee Appointments
Conflict of Interest Committee. Member 2005 - present.
Research Working Group for College of Medicine. Member. 2005.
Steering Committee. University of Tennessee Cancer Institute (UTCI). Member. 2003 – 2006.
Internal Advisory Committee for University of Tennessee Cancer Institute (UTCI). Member. 2002
- 2006.
Research Subcommittee for the Search Committee for the Chancellor and Vice President
Position for the University of Tennessee, Health Science Center. Member. 2002-2003.
Search Committee for the Chairman Position in the Department of Preventive Medicine, College
of Medicine, University of Tennessee, Memphis. Member. 1999.
Faculty Organization of the College of Medicine at the University of Tennessee, Memphis.
Elected Secretary. 1994 - 1997.
Executive Committee for the Faculty Organization of the College of Medicine at the University of
Tennessee, Memphis. Representative for the Department of Preventive Medicine. 1993 - 1998.
University of Tennessee Health Science Center Positions
Past President of the Faculty Senate at the University of Tennessee Health Science Center.
2009 – 2010.
32

President of the Faculty Senate at the University of Tennessee Health Science Center.
2008 – 2009.
President Elect. Faculty Senate at the University of Tennessee Health Science Center.
2007 – 2008.
Research Committee for the Faculty Senate. University of Tennessee, Health Science Center.
Member. 2001- 2010.
Executive Committee for the Faculty Senate at the University of Tennessee Health Science
Center. Elected Member. 2004-2010.
Search Committee for the Vice Chancellor for Research position at the University of Tennessee
Health Science Center. Member 2005.
Search Committee for the Vice Chancellor for Research position at the University of Tennessee
Health Science Center. Member 2010.
Search Committee for the Vice Chancellor for Research position at the University of Tennessee
Health Science Center. Member 2011.
Search Committee for the Dean of the College of Pharmacy position at the University of
Tennessee Health Science Center. Co-Chair and Member 2011.
University of Tennessee, Knoxville Positions
Obesity Center at University of Tennessee, Knoxville, Member. 2010 – present.
University of Tennessee System Positions
University Faculty Council at the University of Tennessee System Level. Member. 2008 – 2011.
Board of Trustee Member. Appointed by the Governor of the State of Tennessee. 2009 – 2011.
UT Bowld Hospital Committee Appointments
Quality Committee. UT Bowld Hospital. Member 1998 - 2003.
Infection Control Committee. UT Bowld Hospital. Member. 1993 - 2000.
Utilization Review Officer. Quality Assessment and Improvement Committee.
UT Bowld Hospital. January 1993.
University of Memphis Committee Appointments
Institutional Review Board (IRB). University of Memphis. Member. 1994 - 2002.
Other Committee Appointments (National)
33

National Steering Committee Vice Chair. SPRINT study. Funded by the NHLBI, NIH. 2010 –
present.
Data Safety Monitoring Committee for the HARP study funded by NIH to the University of
Alabama at Birmingham. Chair and Member. 2005 – 2007.
National Internal Medicine Advisory Committee. Member. Eli Lilly and Company. 2003 - 2008.
National Executive Committee for the Women’s Health Initiative. Elected Member. 2002 - 2004.
Southeastern Regional Principal Investigators Group. Elected Chair. Women’s Health Initiative,
2002- 2004.
National Adjudication Committee for Look AHEAD. Co- Chair and Member. 2001 - present.
National Publications Committee for Look AHEAD. Member. 2001 - 2009.
National Medical Care Committee for Look AHEAD. Member. 2000 - 2001.
National Design and Analysis Committee for the Women’s Health Initiative. Member. 2001 -
present.
National Science Committee. American College of Preventive Medicine. Member. 1993 - 1998.
National Morbidity and Mortality Committee for Cardiovascular Outcomes in the Women's Health
Initiative Study. Member. 1995 - 2001.
National Publications and Presentations Committee for the Women's Health Initiative Study.
Member. 1997 - 1998.
National Case Control Analyte Working Group for the Women’s Health Initiative Study. Member.
2002 - present.
Biomarkers and Genetics Task Force for the Women's Health Initiative Study. Chair. 1999.
National ACNET Executive Committee. Member 1999 - 2007.
National Ultra Executive Committee. Member 2000 - 2007.
National CHIMES Steering Committee. Member 2005 – 2009.
Other Committee Appointments (Local)
American Heart Association. "Heart at Work" Worksite Committee. Member. 1992 - 1995.
Preventive Medicine Advisory Committee. TLC Managed Care Organization. Member. 1994 -
1998.
Memphis City Schools Safety Project. Committee member. 1995 - 1996.
External Reviewer
Journal of the American Geriatrics Society. Reviewer. 1995 - present.
34

American College of Preventive Medicine. Book Reviewer. 1994.
American Journal of Preventive Medicine. Reviewer. 1994 - present.
Hypertension. Reviewer. 1997 - present.
American Journal of Public Health. Reviewer. 1997 - present.
Annuals of Internal Medicine. Reviewer. 2000-present.
Circulation. Reviewer. 2006 – present.
Susan G. Koman Foundation. 2010 - present.
Editorial Board
Clinical Journal of Women’s Health 2000 -2003.
Awards
Memphis Business Journal, Health Care Innovators Finalist, 2011
INVENTIONS OR PATENTS
Quit Forever App for the iPhone. Marketed through iTunes by the University of Tennessee
Research Foundation. 2011.
35